Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Multiple myeloma

Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea

Ka-Won Kang, Min Ji Jeon, [ ... ], Hwa Jung Sung

Prognostic value of RGS1 and mTOR Immunohistochemical expression in Egyptian multiple myeloma patients; A single center study

Nora Hafez, Lobna Refaat, [ ... ], Lamiaa A. Fathalla

Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan

Shuji Uno, Shuichi Midorikawa, [ ... ], Kenshi Suzuki

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study

Anita Marx, Magdolna Osváth, [ ... ], Imre Kacskovics

RWD-derived response in multiple myeloma

Tao Xu, James Roose, [ ... ], Stefka Tyanova

Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders

Hila Magen, Abraham Avigdor, [ ... ], Galia Rahav

Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database

Hiroshi Handa, Tadao Ishida, [ ... ], Shinsuke Iida

Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices

Miyuki Takasu, Ryo Higashino, [ ... ], Kazuo Awai

Calprotectin as new potential clinical marker for multiple myeloma

Parisa Khosravi, Saeid Abroun, [ ... ], Homayoun Sarough Farahani

Evaluating the screening value of serum light chain ratio, β₂ microglobulin, lactic dehydrogenase and immunoglobulin in patients with multiple myeloma using ROC curves

Limei Ying, Xiaochang Zhang, [ ... ], Linglong Xu

Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer

Chandru Gajendran, Subramanyam Janardhan Tantry, [ ... ], Dhanalakshmi Sivanandhan

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

Mailee Huynh, Hae Yeun Chang, [ ... ], Shigeki Miyamoto

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma

Dollapak Apipongrat, Sittiruk Roytrakul, [ ... ], Oytip Nathalang

Advertisement

Create a weekly email alert for: Multiple myeloma

You can change these options by clicking profile then "Alerts and Notifications"